DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 02 · Volume 42 · March 2016 DOI: 10.1055/s-006-31081 At the Crossroads of Transfusion Medicine and Hemostasis Guest Editors: Glenn Ramsey, MD, and Hau C. Kwaan, MD.

Preface

  • 093
    Kwaan, Hau C.; Ramsey, Glenn:

    At the Crossroads of Transfusion Medicine and Hemostasis

  • 095
    Shah, Akshay; McKechnie, Stuart; Stanworth, Simon:

    Use of Plasma for Acquired Coagulation Factor Deficiencies in Critical Care

  • 102
    Dubovoy, Timur; Engoren, Milo:

    Thrombotic Risks in Red Blood Cell Transfusions

  • 112
    Franchini, Massimo; Lippi, Giuseppe:

    Relative Risks of Thrombosis and Bleeding in Different ABO Blood Groups

  • 118
    Schmidt, Amy E.; Refaai, Majed A.; Blumberg, Neil:

    Platelet Transfusion and Thrombosis: More Questions than Answers

  • 125
    Goodnough, Lawrence Tim; Levy, Jerrold H.:

    The Judicious Use of Recombinant Factor VIIa

  • 133
    Curnow, Jennifer; Pasalic, Leonardo; Favaloro, Emmanuel J.:

    Treatment of von Willebrand Disease

  • 147
    Spahn, Donat R.; Spahn, Gabriela H.; Stein, Philipp:

    Indications and Risks of Fibrinogen in Surgery and Trauma

  • 155
    Gando, Satoshi; Hayakawa, Mineji:

    Pathophysiology of Trauma-Induced Coagulopathy and Management of Critical Bleeding Requiring Massive Transfusion

  • 166
    Paparella, Domenico; Whitlock, Richard:

    Safety of Salvaged Blood and Risk of Coagulopathy in Cardiac Surgery

  • 172
    Ramsey, Glenn:

    Hemostatic Efficacy of Pathogen-Inactivated Blood Components